CVE-2026-56402 | NanoClaw before 2.1.17 contains a privilege escalation vulnerability in the handleApprovalsResponse function that fails to verify responder role authorization. Attackers with a valid questionId can approve or reject privileged actions like package installation by submitting approval response payloads without proper role validation.
NanoClaw before 2.1.17 contains a privilege escalation vulnerability in the handleApprovalsResponse function that fails to verify responder role authorization. Attackers with a valid questionId can approve or reject privileged actions like package installation by submitting approval response payloads without proper role validation.
Zero-Day & Vulnerability Intelligence Hub
Echtzeit-Tracking mit EPSS Exploit-Wahrscheinlichkeiten, Angriffsvektor-Decodern und KI-Patch-Anleitungen.
📊 Historien-Charts — Criticals-Trend · Vendors · EPSS-Verteilung
| Tier | 2026-08-29 | 2026-09-13 |
|---|---|---|
| ≥90 % | 4 | 0 |
| ≥50 % | 4 | 0 |
| ≥10 % | 3 | 0 |
| <10 % | 304 | 300 |
CVE-2026-56402 | NanoClaw before 2.1.17 contains a privilege escalation vulnerability in the handleApprovalsResponse function that fails to verify responder role authorization. Attackers with a valid questionId can approve or reject privileged actions like package installation by submitting approval response payloads without proper role validation.
NanoClaw before 2.1.17 contains a privilege escalation vulnerability in the handleApprovalsResponse function that fails to verify responder role authorization. Attackers with a valid questionId can approve or reject privileged actions like